Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345324 | 1.00 | LMNA (0.50) | LMNAALOX15HSD17B10TSHRKDM4E | |
| SCHEMBL316986 | 1.00 | LMNA (0.50) | LMNAALOX15HSD17B10TSHRKDM4E | |
| Acetic Acid SCHEMBL3868358 | 0.92 | LMNA (0.43) | LMNAALOX15HSD17B10TSHRKDM4E | |
| Acetic Acid SCHEMBL3868351 | 0.92 | LMNA (0.43) | LMNAALOX15HSD17B10TSHRKDM4E | |
| Vinyl Chloride SCHEMBL6537138 | 0.92 | LMNA (0.43) | LMNAALOX15HSD17B10TSHRKDM4E | |
| SCHEMBL28414100 | 0.80 | LMNA (0.40) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| SCHEMBL27996425 | 0.79 | ALOX15 (0.47) | LMNAALOX15HSD17B10TSHRKDM4E | |
| Styrene SCHEMBL11119686 | 0.79 | ALDH1A1 (0.52) | LMNATSHRKDM4EALDH1A1TDP1 | |
| SCHEMBL19003733 | 0.78 | LMNA (0.38) | LMNAALOX15HSD17B10TSHRALDH1A1 | |
| SCHEMBL3189966 | 0.78 | LMNA (0.38) | LMNAALOX15HSD17B10TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11316118-B2 | Dibenzo[d,B]silole-based reactive mesogens | LOMOX LIMITED (GB) | 2022-04-26 | — | — | US | claimed |
| EP-3523313-B1 | DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS | LOMOX LTD (GB) | 2021-05-05 | — | — | EP | claimed |
| US-20190280223-A1 | DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS | LOMOX LIMITED (GB) | 2019-09-12 | — | — | US | claimed |
| EP-3523313-A1 | DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS | Lomox Limited (GB) | 2019-08-14 | — | — | EP | claimed |
| WO-2018065786-A1 | DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS | LOMOX LIMITED (GB) | 2018-04-12 | — | — | WO | claimed |
| EP-2483367-B1 | ELECTROLUMINESCENT THIOPHENE DERIVATIVES | LOMOX LTD (GB) | 2015-09-16 | — | — | EP | claimed |
| US-9006435-B2 | Electroluminescent thiophene derivatives | LOMOX LIMITED (GB) | 2015-04-14 | — | — | US | claimed |
| EP-2483368-B1 | ELECTROLUMINESCENT MATERIALS COMPRISING FLUORENE DERIVATIVES | LOMOX LTD (GB) | 2014-12-24 | — | — | EP | claimed |
| US-20120271052-A1 | ELECTROLUMINESCENT THIOPHENE DERIVATIVES | LOMOX LIMITED (GB) | 2012-10-25 | — | — | US | claimed |
| EP-2483367-A1 | ELECTROLUMINESCENT THIOPHENE DERIVATIVES | Lomox Limited (GB) | 2012-08-08 | — | — | EP | claimed |
| WO-2011039505-A1 | ELECTROLUMINESCENT THIOPHENE DERIVATIVES | LOMOX LIMITED (GB) | 2011-04-07 | — | — | WO | claimed |
| CN-110382491-B | Crosslinkable organometallic luminescent ligands and complexes | 洛马克斯有限公司 | 2023-10-20 | — | — | CN | disclosed |
| US-20230123697-A1 | THERAPEUTIC PATCH FOR GASTROINTESTINAL TRACT AND METHOD OF MANUFACTURING SAME | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2023-04-20 | — | — | US | disclosed |
| EP-3592737-B1 | CROSS-LINKABLE ORGANOMETALLIC LIGHT EMITTING COMPLEXES | LOMOX LTD (GB) | 2022-12-21 | — | — | EP | disclosed |
| US-11316118-B2 | Dibenzo[d,B]silole-based reactive mesogens | LOMOX LIMITED (GB) | 2022-04-26 | — | — | US | disclosed |
| US-20130037752-A1 | ELECTROLUMINESCENT MATERIALS COMPRISING FLUORENE DERIVATIVES | LOMOX LIMITED (GB) | 2013-02-14 | — | — | US | disclosed |
| US-20120271052-A1 | ELECTROLUMINESCENT THIOPHENE DERIVATIVES | LOMOX LIMITED (GB) | 2012-10-25 | — | — | US | disclosed |
| EP-2483368-A1 | ELECTROLUMINESCENT MATERIALS COMPRISING FLUORENE DERIVATIVES | Lomox Limited (GB) | 2012-08-08 | — | — | EP | disclosed |
| WO-2011039506-A1 | ELECTROLUMINESCENT MATERIALS COMPRISING FLUORENE DERIVATIVES | LOMOX LIMITED (GB) | 2011-04-07 | — | — | WO | disclosed |
| US-5371132-A | A half-aromatic polyamide comprising adipic acid and isophthalic acid with hexamethylenediamine; inorganic filler; high surface gloss | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1994-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190280223-A1 | DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS | CCNB1, CCNE2, UBE2G2 | LMNA 1000/4885ALOX15 569/4885HSD17B10 345/4885 |
| US-20120271052-A1 | ELECTROLUMINESCENT THIOPHENE DERIVATIVES | AR, NR2E3, NES | LMNA 343/4885ALOX15 4438/4885HSD17B10 3810/4885 |
| US-11316118-B2 | Dibenzo[d,B]silole-based reactive mesogens | CCNB1, CCNE2, UBE2G2 | LMNA 1000/4885ALOX15 569/4885HSD17B10 345/4885 |
| US-20130037752-A1 | ELECTROLUMINESCENT MATERIALS COMPRISING FLUORENE DERIVATIVES | SPIN2B, FLNB, LMNB2 | LMNA 39/4885ALOX15 1074/4885HSD17B10 2175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.